VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
YASKAWA Electric Corporation vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
YASKAWA Electric Corporation
6506 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into YASKAWA Electric Corporation's moat claims, evidence, and risks.
View 6506 analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 62 / 100 for YASKAWA Electric Corporation).
- Segment focus: YASKAWA Electric Corporation has 4 segments (44.4% in Motion Control); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: YASKAWA Electric Corporation has 8 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
YASKAWA Electric Corporation
Motion Control
Factory automation motion control components (AC servo motors/drives & controllers, AC drives/inverters)
Global
Industrial OEMs and end-users (machine builders; semiconductor, electronics, automotive, and general industry plants)
Component manufacturer + maintenance/service provider
44.4%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
YASKAWA Electric Corporation strengths
Amgen Inc. strengths
Segment mix
YASKAWA Electric Corporation segments
Full profile >Motion Control
Oligopoly
Robotics
Oligopoly
System Engineering
Competitive
Other / Logistics Services
Competitive
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.